stars 1 stars 2 stars 3

Tangent90 enables pharma to drive better access and ongoing engagement with healthcare professionals using innovative digital solutions to distribute and support communication of scientific copyright content. Utilising our extensive knowledge of the life sciences industry and working with a network of partners we trust and who trust us, we offer unique solutions which focus on removing hurdles for effective communication such as copyright and publisher term and condition compliance, regulatory requirements, ease of use and ease of access. We go beyond expectation – continually enhancing the solution to incorporate new and innovative channels, working with publishers to deliver new content discovery capabilities, and delivering approaches to increase efficiency. Together we deliver fast, cost-effective, compliant distribution of scientific content that meets the needs of HCPs, and enables the pharmaceutical industry to manage efficiencies and drive successful customer engagement.

Tangent90 Ltd Questions

The Tangent90 Ltd annual revenue was $6.5 million in 2026.

Jan van Den Burg is the CEO of Tangent90 Ltd.

16 people are employed at Tangent90 Ltd.

The NAICS codes for Tangent90 Ltd are [517, 5171, 51711, 513, 517110, 51].

The SIC codes for Tangent90 Ltd are [7375, 737, 73].

Top Tangent90 Ltd Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users